Morgan Stanley Maintains Overweight on JD.com, Lowers Price Target to $85

Morgan Stanley analyst Eddy Wang maintains JD.com (NASDAQ:JD) with a Overweight and lowers the price target from $98 to $85.

byBenzinga Newsdesk

March 7, 2022

1 minute read

Morgan Stanley analyst Eddy Wang maintains JD.com (NASDAQ:JD) with a Overweight and lowers the price target from $98 to $85.

Analyst Ratings

What 5 Analyst Ratings Have To Say About Bed Bath & Beyond

By Benzinga Insights

Today, 10:00 AM

Analysts have provided the following ratings for Bed Bath & Beyond (NASDAQ:BBBY) within the last quarter:

BBBY

News

Booz Allen Hamilton: Return On Capital Employed Insights

By Benzinga Insights

Today, 10:00 AM

Booz Allen Hamilton (NYSE:BAH) showed a loss in earnings since Q3, totaling $171.01 million. Sales, on the other hand, increased by 3.94% to $1.98 billion during Q4. In Q3, Booz Allen Hamilton earned $184.26 million and total sales reached $1.90 billion.

BAH

Cathie Wood Adds Tesla For 7th Time This Month With $3.3M Buy

By Rachit Vats

Today, 10:00 AM

Cathie Wood-led Ark Invest Investment Management added more Tesla Inc (NASDAQ: TSLA) shares to its portfolio on Thursday, raising its exposure to the electric vehicle maker for the seventh time this month.

ARKK

Clever Leaves Partners With Anden Naturals To Bring Pharmaceutical-Grade Cannabis To Patients In Peru

By Benzinga Newsdesk

Today, 10:00 AM

Peruvian operator Anden Naturals has obtained sanitary registration from the Peruvian Health Authority for its THC dominant products Clever Leaves will cultivate, manufacture, and pack Anden Naturals'

CLVR

Morgan Stanley Maintains Overweight on JD.com, Lowers Price Target to $85

Related Posts

What 5 Analyst Ratings Have To Say About Bed Bath & Beyond

Booz Allen Hamilton: Return On Capital Employed Insights

Cathie Wood Adds Tesla For 7th Time This Month With $3.3M Buy

Clever Leaves Partners With Anden Naturals To Bring Pharmaceutical-Grade Cannabis To Patients In Peru